(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

VACINA DE CITOMEGALOVÍRUS HUMANO

ArquivadaInvention PatentPCT · US2021047541

Application data

Number

112023003009

Type

Invention Patent

Filing

08/25/2021

Publication

04/25/2023

PCT

US2021047541

Progress at the INPI

  1. Filing08/25/21
  2. Publication04/25/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 08/25/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 11/19/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MODERNATX, INC.

US

See this company's full portfolio

Inventors

A. C. (pessoa física)

US

J. K. (pessoa física)

US

K. H. (pessoa física)

US

P. W. (pessoa física)

US

S. J. (pessoa física)

US

Technical data

Priority claims

US

63/070,134 · 08/25/2020

US

63/079,421 · 09/16/2020

US

63/136,117 · 01/11/2021

Abstract

VACINA DE CITOMEGALOVÍRUS HUMANO. A presente invenção refere-se a métodos para produzir uma resposta imune específica de antígeno ao citomegalovírus humano (hCMV) em um indivíduo, ao administra-lo vacinas de mRNA.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

11/19/2024

RPI 2811

Arquivamento - Art. 33 da LPI

#11.1

09/03/2024

RPI 2800

Notificação de entrada na fase nacional - PCT

#1.3

04/25/2023

RPI 2729

Alteração de dados cadastrais

#1.1

02/28/2023

RPI 2721

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.